217 related articles for article (PubMed ID: 35589576)
21. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
[TBL] [Abstract][Full Text] [Related]
22. Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007-2030.
Duan R; Xu K; Huang L; Yuan M; Wang H; Qiao Y; Zhao F
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1130-1136. PubMed ID: 35266990
[TBL] [Abstract][Full Text] [Related]
23. [Incidence and mortality of laryngeal cancer in China, 2014].
Wei KR; Zheng RS; Liang ZH; Sun KX; Zhang SW; Li ZM; Zeng HM; Zou XN; Chen WQ; He J
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):736-743. PubMed ID: 30392337
[No Abstract] [Full Text] [Related]
24. Epidemiological dynamic modeling of human papillomavirus-related diseases to assess vaccination strategies in Argentina.
Borracci RA; Segal SV; Méndez JH
Medicina (B Aires); 2018; 78(5):315-328. PubMed ID: 30285924
[TBL] [Abstract][Full Text] [Related]
25. [Analysis on mortality of cervical cancer and its temporal trend in women in China, 2006-2012].
Bao HL; Liu YN; Wang LJ; Fang LW; Cong S; Zhou MG; Wang LH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):58-64. PubMed ID: 28100378
[No Abstract] [Full Text] [Related]
26. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Gilbert DC; Wakeham K; Langley RE; Vale CL
Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
[TBL] [Abstract][Full Text] [Related]
27. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects].
Sophia Rudolph CE; Katalinic A
Gesundheitswesen; 2019 Dec; 81(12):993-1000. PubMed ID: 29933495
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
29. [Cancer incidence and mortality in China, 2022].
Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
[No Abstract] [Full Text] [Related]
30. [Incidence and mortality of cervical cancer in China, 2014].
Gu XY; Zheng RS; Sun KX; Zhang SW; Zeng HM; Zou XN; Chen WQ; He J
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):241-246. PubMed ID: 29730908
[No Abstract] [Full Text] [Related]
31. [Report of Cancer Incidence and Mortality in China, 2014].
Chen WQ; Li H; Sun KX; Zheng RS; Zhang SW; Zeng HM; Zou XN; Gu XY; He J
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):5-13. PubMed ID: 29365411
[No Abstract] [Full Text] [Related]
32. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark.
Olsen J; Jørgensen TR; Kofoed K; Larsen HK
BMC Public Health; 2012 Dec; 12():1082. PubMed ID: 23244352
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus infection by anatomical site among Greek men and women: a systematic review.
Tsikis S; Hoefer L; Charnot-Katsikas A; Schneider JA
Eur J Cancer Prev; 2016 Nov; 25(6):558-71. PubMed ID: 26628088
[TBL] [Abstract][Full Text] [Related]
34. Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer.
Cook EE; Gershman ST; Kim JJ; Tamimi RM; Klevens RM; Holmes MD
Cancer Causes Control; 2018 May; 29(4-5):435-443. PubMed ID: 29497883
[TBL] [Abstract][Full Text] [Related]
35. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.
Choi I; Lee D; Son KB; Bae S
BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300
[TBL] [Abstract][Full Text] [Related]
36. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
[TBL] [Abstract][Full Text] [Related]
37. Geographic and temporal variations in the incidence of vulvar and vaginal cancers.
Bray F; Laversanne M; Weiderpass E; Arbyn M
Int J Cancer; 2020 Nov; 147(10):2764-2771. PubMed ID: 32410226
[TBL] [Abstract][Full Text] [Related]
38. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
39. Mortality trends and prediction of HPV-related cancers in Brazil.
de Souza DL; Curado MP; Bernal MM; Jerez-Roig J; Boffetta P
Eur J Cancer Prev; 2013 Jul; 22(4):380-7. PubMed ID: 23238584
[TBL] [Abstract][Full Text] [Related]
40. [Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989-2008].
Hu SY; Zheng RS; Zhao FH; Zhang SW; Chen WQ; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Apr; 36(2):119-25. PubMed ID: 24791788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
